NFE2L2 and metabolic dysfunction-associated steatotic liver disease: Resveratrol (3) was shown to attenuate methylation of the Nrf2 promoter in the liver of mice fed a high-fat diet (HFD) and attenuated NAFLD through epigenetic modification of Nrf2 signaling [160].